University of Oklahoma
Oklahoma City, Oklahoma, United States
Public university in Norman, Oklahoma
660 Parrington Oval, Norman, OK 73019
About University of Oklahoma
The University of Oklahoma is a public research university in Norman, Oklahoma. Founded in 1890, it had existed in Oklahoma Territory near Indian Territory for 17 years before the two became the state of Oklahoma. In Fall 2018 the university had 31,702 students enrolled, most at its main campus in Norman.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Oklahoma
11
SCRI Development Innovations, LLC
7
Biosense Webster, Inc.
5
National Cancer Institute (NCI)
5
Yale University
5
Major Extremity Trauma Research Consortium
4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
4
Agendia
3
Boehringer Ingelheim
3
ImmunoGen, Inc.
3
Novartis Pharmaceuticals
3
Clinical Trials at University of Oklahoma
During the past decade, University of Oklahoma conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 43 clinical trials were completed, i.e. on
average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 17 clinical trials were completed. i.e. 73.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
Completed
1,250
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
Completed
140
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
Completed
3,000
Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
1998-04-01
Unknown status
400
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
2002-01-01
2003-07-01
Completed
60
Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
2002-01-01
Completed
3,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Oklahoma" #1 sponsor was "University of Oklahoma" with 11 trials, followed by "SCRI Development Innovations, LLC" with 7 trials
sponsored, "Biosense Webster, Inc." with 5 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored and "Yale University"
with 5 trials sponsored. Other sponsors include 131 different institutions and
companies that sponsored additional 109 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Oklahoma"
#1 collaborator was "University of Oklahoma" with 11 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Penn State University" with 5 trials as a collaborator and "University of Pennsylvania" with 5 trials as a collaborator. Other collaborators include 144 different institutions and companies that were
collaborators in the rest 113 trials.
Clinical Trials Conditions at University of Oklahoma
According to Clinical.Site data, the most researched conditions in "University of Oklahoma" are
"Breast Cancer" (6 trials), "Ovarian Cancer" (5 trials), "Cervical Cancer" (4 trials), "HIV Infections" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "University of Oklahoma" in a lesser frequency.
Clinical Trials Intervention Types at University of Oklahoma
Most popular intervention types in "University of Oklahoma" are "Drug" (88 trials), "Procedure" (28 trials), "Device" (26 trials), "Biological" (21 trials) and "Other" (18 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Methotrexate" (4 trials), "Carboplatin" (3 trials), "Cyclophosphamide" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at University of Oklahoma
The vast majority of trials in "University of Oklahoma" are
130 trials for "All" genders, 34 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at University of Oklahoma
Currently, there are NaN active trials in "University of Oklahoma".
1 are not yet recruiting,
28 are recruiting,
15 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 98 completed trials in University of Oklahoma,
undefined suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in University of Oklahoma, 25 "Phase 1"
clinical trials were conducted, 47 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 29 trials that are defined as “Not Applicable".